Historia

« Back to Pipeline

Operationes nostrae:

Surrentum longum iter ab humili origine ad variam biopharma inveniendam et vitam mutandam medicinam explicandam habuit.

2009

Founded

2013

Resiniferatoxin quaesita (RTX) bonorum per acquisitionem Sherrington Pharmaceuticals Inc.
Acquisita technologiae technologiae Anticorpus medicamenti Conjugationis per Concortis Biosystematum acquirendum.

2014

Out-licentiati PD-L1 ad Maiorem Sinarum forum ad Lee Pharm

2016

ImmuneOncia JV cum Yuhan Pharmaceuticals formatus
Acquiritur ZTlido® via maioris agitur in Scilex pharmaceutical
Acquisita Bioserv Corporation pro cGMP operationibus fabricandis
Formavit Levena Suzhou Biopharma Co. LTD pro Anticorpore medicamentis Conjugatio (ADC) officia

2017

Viris oncolyticis quaesita suggestu per acquisitionem Virttu biologicorum limitatum
Coeruleus formatus cum Celgene et Iunctus Therapeutica

2018

Acquiritur Sofusa® Systema lymphaticorum Delivery a Kimberly-Clark

2019

Acquiritur Semnur Pharmaceuticals
Formatum Scilex habens consolidandum merger Scilex Pharma et Semnur Pharma

2020

Exclusive licentiati Abivertinib ab ACEA Therapeutica pro omnibus mundi indiciis, Sinis exclusis
Exclusive licentiatus diagnostica HP-LAMP e Columbia University ad detectionem virus coronavirorum et virus influenzae
Acquiritur SmartPharm Therapeutics

2021

ACEA Therapeutica quaesita

2022

quaesita Virexhealth